Re:Gender works to end gender inequity by exposing root causes and advancing research-informed action. Working with multiple sectors and disciplines, we are shaping a world that demands fairness across difference.

In a study of 8,300 women ages 18 to 30, the vaccine, developed by GlaxoSmithKline, partially protected against HSV-1, the strain of herpes which typically causes cold sores but can also cause genital herpes. The vaccine, however, did not protect against HSV-2, the strain that most commonly causes genital herpes.